Status:

ACTIVE_NOT_RECRUITING

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Myelodysplastic Syndrome

Myeloproliferative Neoplasms

Eligibility:

All Genders

60+ years

Phase:

PHASE2

Brief Summary

This study will evaluate whether a geriatric assessment can lead to better treatment outcomes in older patients (age 60+) with a myeloid malignancy including acute myeloid leukemia, ,myelodysplastic s...

Detailed Description

This is a prospective, phase II study evaluating the efficacy of a risk-adapted, personalized allo-HCT strategy based on geriatric vulnerabilities identified by pre-transplant GA. The less vulnerable/...

Eligibility Criteria

Inclusion

  • are 60 years or older
  • have a pathologically confirmed myeloid malignancies including acute myeloid leukemia, ,myelodysplastic syndrome, myeloproliferative neoplasms, or related blood disorders including chronic myelomonocytic leukemia, atypical chronic myeloid leukemia, and myelodysplastic/myeloproliferative overlapping syndrome
  • have \<10% blasts in bone marrow prior to transplant
  • have a matched related or unrelated donor, mismatched unrelated donor, or haploidentical donor
  • Meet institutional standard criteria for allogeneic transplantation as determined by the primary transplant physician
  • Undergoes transplantation using the allocated conditioning regimen intensity defined by the protocol-specified criteria below:
  • HCT-CI/Age \<5 and IADL normal = myeloablative regimen
  • HCT-CI/Age ≥5 and/or IADL impairment = RIC/NMA regimen

Exclusion

  • Prior hematopoietic cell transplantation
  • Cord blood donors
  • Persons with active, refractory disease defined by ≥10% blasts in bone marrow prior to transplant

Key Trial Info

Start Date :

February 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2026

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT04761770

Start Date

February 15 2021

End Date

February 1 2026

Last Update

February 11 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

2

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States, 07748

3

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States, 07645

4

Memorial Sloan Kettering Commack (Consent only)

Commack, New York, United States, 11725